Skip to content

Evaluation of the Effects of Two Biostimulators on Skin Quality: A Split-Face Study Comparing a Hyaluronic Acid Gel Enriched with Glycine, L-Proline, and Calcium Hydroxylapatite (CaHA) with a Non-Cross-Linked Hyaluronic Acid Gel (HA)

Evaluation of the Effects of Two Biostimulators on Skin Quality: A Split-Face Study Comparing a Hyaluronic Acid Gel Enriched with Glycine, L-Proline, and Calcium Hydroxylapatite (CaHA) with a Non-Cross-Linked Hyaluronic Acid Gel (HA) - NEAUVIA-PROFHILO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00041122
Enrollment
20
Registered
2026-07-29
Start date
2026-07-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

loss of skin quality in healthy skin

Interventions

Group 1: NEAUVIA Hydro Deluxe (HACaHA) – 2,5 mL, one side of the face Group 2: Profhilo® (non-cross-linked HA) – 2 mL, contralateral side of the face

Sponsors

Universität Hamburg Fakultät für Mathematik, Informatik und Naturwissenschaften (MIN) Institut für Biochemie und Molekularbiologie Fachbereich Kosmetikwissenschaft
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female sex Age between 18 and 65 years (inclusive) Generally good state of health Understanding of and agreement to the study procedures Sufficient time availability for the duration of the study No inflammatory skin conditions in the treatment area Self-assessed skin quality score = 50% on the questionnaire Expert rating of at least "mild" (1) at rest and "moderate" (2) at maximum smiling, at V1 SASSQ rating with at least three of six categories scoring = 2 ("moderate"), at V1

Exclusion criteria

Exclusion criteria: Pregnancy, breastfeeding, or planned pregnancy / egg donation Use or topical application of medications affecting skin quality (e.g., retinoids) Use of anticoagulants or anti-inflammatory drugs Clinically relevant skin, autoimmune, or collagen diseases Smoking (current or within the last 6 months) Previous invasive or minimally invasive aesthetic treatments in the study area within the last 12 months Permanent fillers and implants in the study area Excessive UV exposure, current or past Tattoos or significant scars on the face Participation in another clinical study within the last 30 days Contact of the study area with substances, skincare products, or cleaning products, as well as water, within the last 6 hours

Design outcomes

Primary

MeasureTime frame
Comparison of biophysical parameters of skin quality—including hydration, transepidermal water loss (TEWL), elasticity, skin thickness/density, erythema and melanin indices, sebum levels, and surface texture—before and after treatment.

Secondary

MeasureTime frame
Self-assessment, satisfaction, tolerability, SASSQ/GAIS expert ratings, wrinkle depth, and photographic evaluation

Countries

Germany

Contacts

Public ContactKristina Carmen Bernhöft

Universität Hamburg Fachbereich Chemie Arbeitsgruppenleitung AG Kerscher Institut für Biochemie und Molekularbiologie

kristina.bernhoeft@uni-hamburg.de+4940239527235

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026